Clinical Trials Logo

Dysplasia, Congenital Hip clinical trials

View clinical trials related to Dysplasia, Congenital Hip.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT02253810 Completed - Clinical trials for Dysplasia, Congenital Hip

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

Start date: October 2014
Phase: N/A
Study type: Interventional

The goal of this randomized controlled, double-blinded trial is to assess the efficacy of intravenous tranexamic acid, a drug, in reducing blood loss and transfusion in patients undergoing periacetabular osteotomy, an elective reorientation procedure for the hip joint. The investigators hypothesize that tranexamic acid will be more effective than placebo (normal saline solution) in reducing blood loss and transfusion after periacetabular osteotomy.